Trial
NCT04322227
Study Investigating Effects of Foliglurax in Patients With Parkinson's Disease (PD) and Healthy Subjects
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
H. Lundbeck A/S
Collaborators
—
Condition
Parkinson Disease
Intervention
Foliglurax 10 mg (treatment A)
Why stopped
Study termination due to efficacy results of another study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-07-07